Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIIOngoingAug 5, 2026Dabigatran Etexilate CapsulesFailed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month...Ascend Laboratories, LLC · D-0738-2026Class IIIOngoingAug 5, 2026Dabigatran Etexilate CapsulesFailed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month...Ascend Laboratories, LLC · D-0737-2026Class IIOngoingAug 5, 2026Mycophenolate Mofetil for Injection USPPresence of precipitateMylan Pharmaceuticals Inc · D-0734-2026Class IIOngoingAug 5, 2026Azelaic Acid GelCGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.Glenmark Pharmaceuticals Inc., USA · D-0731-2026Class IIOngoingAug 5, 2026Dorzolamide HCl and Timolol Maleate Ophthalmic SolutionDefective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.Micro Labs USA Inc · D-0730-2026Class IIIOngoingJul 29, 2026Trokendi XRFailed Dissolution SpecificationsSupernus Pharmaceuticals, Inc. · D-0758-2026Class IIOngoingJul 29, 2026Divalproex Sodium Delayed-Release TabletsPresence of Foreign Tablets/CapsulesBionpharma Inc. · D-0742-2026Class IIOngoingJul 29, 2026Glycopyrrolate Oral SolutionFailed Impurities/Degradation SpecificationsPrecision Dose Inc. · D-0741-2026Class IIIOngoingJul 29, 2026Dabigatran etexilate CapsulesFailed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total...Ascend Laboratories, LLC · D-0736-2026Class IIIOngoingJul 29, 2026Dabigatran etexilate CapsulesFailed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total...Ascend Laboratories, LLC · D-0735-2026Class IOngoingJul 29, 2026Cetirizine Hydrochloride Tablets USP 5 mgCross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg...JB Chemicals and Pharmaceuticals Ltd · D-0732-2026Class IIOngoingJul 29, 2026XylocainePresence of Particulate Matter: Hair was found in productsFresenius Kabi USA, LLC · D-0729-2026Class IIOngoingJul 29, 2026XylocainePresence of Particulate Matter: Hair was found in productsFresenius Kabi USA, LLC · D-0728-2026Class IIOngoingJul 29, 2026NaropinPresence of Particulate Matter: Hair was found in productsFresenius Kabi USA, LLC · D-0727-2026Class IIOngoingJul 29, 2026Lidocaine HCl InjectionPresence of Particulate Matter: Hair was found in productsFresenius Kabi USA, LLC · D-0726-2026Class IIOngoingJul 29, 2026Glycopyrrolate InjectionPresence of Particulate Matter: Hair was found in productFresenius Kabi USA, LLC · D-0725-2026Class IIOngoingJul 29, 2026Rising, Cyproheptadine Hydrochloride SyrupPresence of Precipitate: medication was crystallizing and particles floating in the bottleRising Pharma Holding, Inc. · D-0724-2026Class IIOngoingJul 29, 2026Rohto Cooling Eye Drops Cool ReliefLack of Assurance of SterilityRohto-Mentholatum (Vietnam) Co., Ltd. · D-0722-2026Class IIOngoingJul 29, 2026Rohto Cooling Eye Drops Dry AidLack of Assurance of SterilityRohto-Mentholatum (Vietnam) Co., Ltd. · D-0721-2026Class IIOngoingJul 29, 2026Rohto Cooling Eye Drops Dry AidLack of Assurance of SterilityRohto-Mentholatum (Vietnam) Co., Ltd. · D-0720-2026Class IIOngoingJul 29, 2026Rohto Cooling Eye Drops Digi EyeLack of Assurance of SterilityRohto-Mentholatum (Vietnam) Co., Ltd. · D-0719-2026Class IIOngoingJul 29, 2026Rohto Cooling Eye Drops Optic GlowLack of Assurance of SterilityRohto-Mentholatum (Vietnam) Co., Ltd. · D-0718-2026Class IIOngoingJul 29, 2026Rohto Cooling Eye Drops Max StrengthLack of Assurance of SterilityRohto-Mentholatum (Vietnam) Co., Ltd. · D-0717-2026Class IIOngoingJul 29, 2026Rohto Cooling Eye Drops Max StrengthLack of Assurance of SterilityRohto-Mentholatum (Vietnam) Co., Ltd. · D-0716-2026Class IIOngoingJul 29, 2026Rohto Cooling Eye Drops ALL-IN-ONELack of Assurance of SterilityRohto-Mentholatum (Vietnam) Co., Ltd. · D-0715-2026Class IIIOngoingJul 29, 2026Lidolog KitLabeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scanAsclemed USA Inc. · D-0713-2026Class IIOngoingJul 29, 2026Amlodipine and Olmesartan Medoxomil TabletsFailed Dissolution Specifications; Olmesartan Medoxomil content below specificationsAscend Laboratories, LLC · D-0712-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0711-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0710-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0709-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0708-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0707-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0706-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0705-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0704-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0703-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0702-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0701-2026Class IIOngoingJul 29, 2026Levothyroxine Sodium TabletsSubpotent DrugMajor Pharmaceuticals · D-0700-2026Class IIOngoingJul 22, 2026BD ChloraPrep ClearLack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicatorCareFusion 213, LLC · D-0690-2026

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.